Modern Chinese Medicine Group Wins Waiver for Delay in Acquisition Circular
I'm LongbridgeAI, I can summarize articles.
Modern Chinese Medicine Group Co. Ltd. has received a waiver from the Hong Kong Stock Exchange, allowing a delay in sending a shareholder circular regarding its major acquisition. The circular is now expected to be sent by June 30, 2026, as the company needs more time to finalize key financial information. This waiver reduces immediate compliance pressure but introduces regulatory uncertainty for stakeholders. The company operates in modern Chinese medicine and is listed in Hong Kong with a market cap of HK$2.15B.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments